The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines

Oral Oncology

Volumn 43, Issue 7, 2007, Pages 701-712

  White, Jason S ^a,d   Weissfeld, Joel L ^a,d   Ragin, Camille C R ^a,d   Rossie, Karen M ^c   Martin, Christa Lese ^a   Shuster, Michele ^a   Ishwad, Chandramohan S ^a   Law, John C ^a   Myers, Eugene N ^b   Johnson, Jonas T ^b   Gollin, Susanne M ^a,b,d  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Alcohol; Chromosome 11; Gene amplification; Head and neck; Human papillomavirus; Squamous cell carcinoma; Tobacco

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RESEARCH; CANCER RISK; CANCER STAGING; CARCINOMA CELL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE AMPLIFICATION; GENETIC ANALYSIS; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ADULT; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FEMALE; HISTORY, 18TH CENTURY; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; RISK FACTORS;

EID: 34447302548     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2006.09.001     Document Type: Article

References (68)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics, 2006, CA. Cancer J Clin 56 2 (2006) 106-130
2. Forastiere A., Koch W., Trotti A., and Sidransky D. Head and neck cancer. N Engl J Med 345 26 (2001) 1890-1900
3. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., et al. Cancer statistics, 2005, CA. Cancer J Clin 55 1 (2005) 10-30
4. Kim M.M., and Califano J.A. Molecular pathology of head-and-neck cancer. Int J Cancer 112 4 (2004) 545-553
5. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al. SEER Cancer Statist Rev, 1975-2002. SEER website 2005: http://seer.cancer.gov/csr/1975_2002.
6. Califano J., van der Riet P., Westra W., Nawroz H., Clayman G., Piantadosi S., et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56 11 (1996) 2488-2492
7. Schwartz G.J., Mehta R.H., Wenig B.L., Shaligram C., and Portugal L.G. Salvage treatment for recurrent squamous cell carcinoma of the oral cavity. Head Neck 22 1 (2000) 34-41
8. Xi S., and Grandis J.R. Gene therapy for the treatment of oral squamous cell carcinoma. J Dent Res 82 1 (2003) 11-16
9. Califano J., Westra W.H., Meininger G., Corio R., Koch W.M., and Sidransky D. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res 6 2 (2000) 347-352
10. Slaughter D.P., Southwick H.W., and Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6 5 (1953) 963-968
11. Gollin S.M. Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck 23 3 (2001) 238-253
12. Reshmi S.C., and Gollin S.M. Chromosomal instability in oral cancer cells. J Dent Res 84 2 (2005) 107-117
13. Hecht S.S. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 3 10 (2003) 733-744
14. Hunter K.D., Parkinson E.K., and Harrison P.R. Profiling early head and neck cancer. Nat Rev Cancer 5 2 (2005) 127-135
15. Gillison M.L., Koch W.M., and Shah K.V. Human papillomavirus in head and neck squamous cell carcinoma: are some head and neck cancers a sexually transmitted disease?. Curr Opin Oncol 11 3 (1999) 191-199
16. Gillison M.L., Koch W.M., Capone R.B., Spafford M., Westra W.H., Wu L., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92 9 (2000) 709-720
17. Herrero R., Castellsague X., Pawlita M., Lissowska J., Kee F., Balaram P., et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 95 23 (2003) 1772-1783
18. Koch W.M., Lango M., Sewell D., Zahurak M., and Sidransky D. Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope 109 10 (1999) 1544-1551
19. Mork J., Lie A.K., Glattre E., Hallmans G., Jellum E., Koskela P., et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344 15 (2001) 1125-1131
20. Braakhuis B.J., Snijders P.J., Keune W.J., Meijer C.J., Ruijter-Schippers H.J., Leemans C.R., et al. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 96 13 (2004) 998-1006
21. Ragin CCR, Taioli E, Weissfeld JL, White JS, Rossie KM, Modugno F, et al. 11q13 amplification status and HPV in relation to p16 expression defines two distinct etiologies of head and neck tumors. Brit J Cancer, in press.
22. Kutler D.I., Auerbach A.D., Satagopan J., Giampietro P.F., Batish S.D., Huvos A.G., et al. High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg 129 1 (2003) 106-112
23. Worsham M.J., Wolman S.R., Carey T.E., Zarbo R.J., Benninger M.S., and Van Dyke D.L. Chromosomal aberrations identified in culture of squamous carcinomas are confirmed by fluorescence in situ hybridisation. Mol Pathol 52 1 (1999) 42-46
24. Lese C.M., Rossie K.M., Appel B.N., Reddy J.K., Johnson J.T., Myers E.N., et al. Visualization of INT2 and HST1 amplification in oral squamous cell carcinomas. Genes Chromosomes Cancer 12 4 (1995) 288-295
25. Lese CM, Reshmi SC, Ried T, Gottberg W, Wilson JW, Reddy JK, et al. Genomic imbalances and patient outcome in oral squamous cell carcinoma, in preparation.
26. Law J.C., Whiteside T.L., Gollin S.M., Weissfeld J., El Ashmawy L., Srivastava S., et al. Variation of p53 mutational spectra between carcinoma of the upper and lower respiratory tract. Clin Cancer Res 1 7 (1995) 763-768
27. Ishwad C.S., Shuster M., Bockmuhl U., Thakker N., Shah P., Toomes C., et al. Frequent allelic loss and homozygous deletion in chromosome band 8p23 in oral cancer. Int J Cancer 80 1 (1999) 25-31
28. Telmer C.A., An J., Malehorn D.E., Zeng X., Gollin S.M., Ishwad C.S., et al. Detection and assignment of TP53 mutations in tumor DNA using peptide mass signature genotyping. Hum Mutat 22 2 (2003) 158-165
29. Fogh J. Human tumor lines for cancer research. Cancer Invest 4 2 (1986) 157-184
30. Carey T.E. Head Neck Tumor Cell Lines (1994) 79-120
31. Heo D.S., Snyderman C., Gollin S.M., Pan S., Walker E., Deka R., et al. Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Cancer Res 49 18 (1989) 5167-5175
32. Hinds P.W., Dowdy S.F., Eaton E.N., Arnold A., and Weinberg R.A. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 91 2 (1994) 709-713
33. Musgrove E.A., Lee C.S., Buckley M.F., and Sutherland R.L. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc Natl Acad Sci USA 91 17 (1994) 8022-8026
34. Zwijsen R.M., Klompmaker R., Wientjens E.B., Kristel P.M., van der Burg B., and Michalides R.J. Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit. Mol Cell Biol 16 6 (1996) 2554-2560
35. Jiang W., Kahn S.M., Zhou P., Zhang Y.J., Cacace A.M., Infante A.S., et al. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 8 12 (1993) 3447-3457
36. Bartkova J., Lukas J., Muller H., Strauss M., Gusterson B., and Bartek J. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res 55 4 (1995) 949-956
37. Robles A.I., Larcher F., Whalin R.B., Murillas R., Richie E., Gimenez-Conti I.B., et al. Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia. Proc Natl Acad Sci USA 93 15 (1996) 7634-7638
38. de Jong J.S., van Diest P.J., Michalides R.J., and Baak J.P. Concerted overexpression of the genes encoding p21 and cyclin D1 is associated with growth inhibition and differentiation in various carcinomas. Mol Pathol 52 2 (1999) 78-83
39. Xu L., Davidson B.J., Murty V.V., Li R.G., Sacks P.G., Garin-Chesa P., et al. TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines. Int J Cancer 59 3 (1994) 383-387
40. Ritchie J.M., Smith E.M., Summersgill K.F., Hoffman H.T., Wang D., Klussmann J.P., et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 104 3 (2003) 336-344
41. Schlecht N.F. Prognostic value of human papillomavirus in the survival of head and neck cancer patients: an overview of the evidence. Oncol Rep 14 5 (2005) 1239-1247
42. Cooper J.S., Pajak T.F., Rubin P., Tupchong L., Brady L.W., Leibel S.A., et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 17 3 (1989) 449-456
43. Sturgis E.M., and Miller R.H. Second primary malignancies in the head and neck cancer patient. Ann Otol Rhinol Laryngol 104 12 (1995) 946-954
44. Bhattacharyya N., and Nayak V.K. Survival outcomes for second primary head and neck cancer: a matched analysis. Otolaryngol Head Neck Surg 132 1 (2005) 63-68
45. Leon X., Quer M., Diez S., Orus C., Lopez-Pousa A., and Burgues J. Second neoplasm in patients with head and neck cancer. Head Neck 21 3 (1999) 204-210
46. Carey T.E., Kimmel K.A., Schwartz D.R., Richter D.E., Baker S.R., and Krause C.J. Antibodies to human squamous cell carcinoma. Otolaryngol Head Neck Surg 91 5 (1983) 482-491
47. Buchhagen D.L., Worsham M.J., Dyke D.L., and Carey T.E. Two regions of homozygosity on chromosome 3p in squamous cell carcinoma of the head and neck: comparison with cytogenetic analysis. Head Neck 18 6 (1996) 529-537
48. Weichselbaum R.R., Dahlberg W., Beckett M., Karrison T., Miller D., Clark J., et al. Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients. Proc Natl Acad Sci USA 83 8 (1986) 2684-2688
49. Prime S.S., Nixon S.V., Crane I.J., Stone A., Matthews J.B., Maitland N.J., et al. The behaviour of human oral squamous cell carcinoma in cell culture. J Pathol 160 3 (1990) 259-269
50. Grenman R., Carey T.E., McClatchey K.D., Wagner J.G., Pekkola-Heino K., Schwartz D.R., et al. In vitro radiation resistance among cell lines established from patients with squamous cell carcinoma of the head and neck. Cancer 67 11 (1991) 2741-2747
51. Masters J.R.W., and Palsson B. Cancer Cell Lines Part 2 vol. II (1999)
52. Virgilio L., Shuster M., Gollin S.M., Veronese M.L., Ohta M., Huebner K., et al. FHIT gene alterations in head and neck squamous cell carcinomas. Proc Natl Acad Sci USA 93 18 (1996) 9770-9775
53. Shuster M.I., Han L., Le Beau M.M., Davis E., Sawicki M., Lese C.M., et al. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification. Genes Chromosomes Cancer 28 2 (2000) 153-163
54. Saunders W.S., Shuster M., Huang X., Gharaibeh B., Enyenihi A.H., Petersen I., et al. Chromosomal instability and cytoskeletal defects in oral cancer cells. Proc Natl Acad Sci USA 97 1 (2000) 303-308
55. Sun P.C., Uppaluri R., Schmidt A.P., Pashia M.E., Quant E.C., Sunwoo J.B., et al. Transcript map of the 8p23 putative tumor suppressor region. Genomics 75 1-3 (2001) 17-25
56. Huang X., Gollin S.M., Raja S., and Godfrey T.E. High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci USA 99 17 (2002) 11369-11374
57. Lango M.N., Dyer K.F., Lui V.W., Gooding W.E., Gubish C., Siegfried J.M., et al. Gastrin-releasing peptide receptor-mediated autocrine growth in squamous cell carcinoma of the head and neck. J Natl Cancer Inst 94 5 (2002) 375-383
58. Xi S., Zhang Q., Dyer K.F., Lerner E.C., Smithgall T.E., Gooding W.E., et al. Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck. J Biol Chem 278 34 (2003) 31574-31583
59. Toomes C., Jackson A., Maguire K., Wood J., Gollin S., Ishwad C., et al. The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis. Genes Chromosomes Cancer 37 2 (2003) 132-140
60. Ragin C.C., Reshmi S.C., and Gollin S.M. Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line. Int J Cancer 110 5 (2004) 701-709
61. Reshmi S.C., Saunders W.S., Kudla D.M., Ragin C.R., and Gollin S.M. Chromosomal instability and marker chromosome evolution in oral squamous cell carcinoma. Genes Chromosomes Cancer 41 1 (2004) 38-46
62. Hewitt C., Wilson P., McGlinn E., MacFarlane G., Papageorgiou A., Woodwards R.T., et al. DLC1 is unlikely to be a primary target for deletions on chromosome arm 8p22 in head and neck squamous cell carcinoma. Cancer Lett 209 2 (2004) 207-213
63. Reing J.E., Gollin S.M., and Saunders W.S. The occurrence of chromosome segregational defects is an intrinsic and heritable property of oral squamous cell carcinoma cell lines. Cancer Genet Cytogenet 150 1 (2004) 57-61
64. Hoffelder D.R., Luo L., Burke N.A., Watkins S.C., Gollin S.M., and Saunders W.S. Resolution of anaphase bridges in cancer cells. Chromosoma 112 8 (2004) 389-397
65. Quintyne N.J., Reing J.E., Hoffelder D.R., Gollin S.M., and Saunders W.S. Spindle multipolarity is prevented by centrosomal clustering. Science 307 5706 (2005) 127-129
66. Ferris R.L., Martinez I., Sirianni N., Wang J., Lopez-Albaitero A., Gollin S.M., et al. Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis. Eur J Cancer 41 5 (2005) 807-815
67. Sirianni N., Wang J., and Ferris R.L. Antiviral activity of Cidofovir on a naturally human papillomavirus-16 infected squamous cell carcinoma of the head and neck (SCCHN) cell line improves radiation sensitivity. Oral Oncol 41 4 (2005) 423-428
68. Lin CJ, Grandis JR, Carey TE, Gollin SM, Whiteside TL, Koch WM, et al. Head and neck squamous cell carcinoma cell lines: established models and rationale for selection. Head Neck, in press.